October, 2023

article thumbnail

Expert: Celebrating Pharmacists’ Role in Health Care, How the Profession Has Changed

Pharmacy Times

The assistant program director at Mayo Clinic discusses the significance of pharmacists’ role in health care, changes throughout the industry, and her passion for mentoring pharmaceutical students.

article thumbnail

Patient groups have become a powerhouse in R&D. Here’s a look at their impact.

PharmaVoice

“They have the money,” and they’re using it to influence drug development, according to the executive director of the IQVIA Institute for Human Data Science.

321
321
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NCPA launches company to assist pharmacies with litigation against PBMs over DIR fees

Fierce Healthcare

The National Community Pharmacists Association (NCPA) has launched the latest salvo in its battle with pharmacy benefit managers over controversial fees. | The National Community Pharmacists Association has launched the latest salvo in its battle with pharmacy benefit managers over controversial fees.

121
121
article thumbnail

DIR Fee Changes Are Coming in 2024: Are you Prepared?

Drug Topics

Lisa Faast, CEO and Owner of DiversifyRx, discusses ways that pharmacists can prepare their business for the cash crunch that is set to happen in the first several months of next year.

568
568
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

What Are Pharmacy Students Up To These Days Anyways? – A Look At The ChatRx Podcast

IDStewardship

In this article the students from the University of Florida discuss why they started the ChatRx podcast and what their goals are for their new endeavor. Written By: Eisha Ludtke, Pharm.D. Candidate 2024 & Lucas Zhou, Pharm.D. Candidate 2024 Article Posted October 2024 Hello Readers of IDstewardship! My name is Eisha Ludtke, and I am a 4th year pharmacy student at the University of Florida (UF).

182
182
article thumbnail

STAT+: In major test for prime editing, scientists successfully correct mutations in monkeys

STAT

Prime Medicine said Friday it successfully used a new, ultra-versatile form of genetic surgery called prime editing to edit liver cells in monkeys. The results, presented at the European Society of Gene & Cell Therapy meeting in Brussels, are a major step for a technology that could transform treatment of numerous diseases. “I think the big celebration here is we’re showing, in primates, for the company, that we have a delivery system that is working and is safe,” said J

145
145

More Trending

article thumbnail

Actor and epilepsy advocate Greg Grunberg wants the world to ‘talk about it’

PharmaVoice

The actor of “Heroes” and “Star Wars: The Force Awakens” fame is starring in another role as a patient advocate for people with epilepsy.

347
347
article thumbnail

Medical AI scribe startup Nabla rolling out tool to Kaiser Permanente docs in Northern California

Fierce Healthcare

Nabla, maker of an autonomous clinical AI scribe, has joined forces with Kaiser Permanente to roll out its tool to 10,000 doctors in Northern California. | The AI tool will be available to 10,000 Kaiser Permanente doctors in Northern California across all care settings and specialties.

145
145
article thumbnail

In the Opioid Epidemic, Treatment Challenges Still Persist

Drug Topics

Despite societal need, stigma around MAT and MOUD still exists.

551
551
article thumbnail

UPDATED: Pfizer plans to shutter New Jersey site, discloses layoffs amid $3.5B cost-cutting drive

Fierce Pharma

Editor's note: This story has been updated with a comment from Pfizer. An earlier version of the story stated that nearly 800 jobs would be affected. | After plunging COVID revenues prompted Pfizer to embark on a cost-cutting crusade, more details about the company's savings efforts are coming into focus.

143
143
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: ALS patients support bill that could help patients with other rare diseases

STAT

WASHINGTON — A month after advisers to the Food and Drug Administration overwhelmingly voted against the experimental ALS drug NurOwn, a Senate committee is considering a bill that would allow provisional approvals of the drug and other investigational treatments for rare, incurable diseases. Balancing high approval standards and fast access to promising drugs has always been a wobbly act.

FDA 145
article thumbnail

Physical Activity Positively Impacts Symptoms of Depression, Anxiety

Pharmacy Times

Modern society has put individuals at an increased risk of dopamine overload, causing an increase in mental health disorders.

158
158
article thumbnail

The ALS therapy keeping the human pig heart transplant pumping

PharmaVoice

Eledon’s investigational ALS drug tegoprubart could also help prevent organ transplant rejections, the company says.

321
321
article thumbnail

Lawmakers mull lifting ban on physician-owned hospitals as doc lobbying groups claim major cost savings

Fierce Healthcare

A new analysis backed by doctor lobbying groups suggest that physician-owned hospitals could have fueled about $1.1 billion in savings across 20 of Medicare’s most expensive conditions in 2019— tho | Lobbying groups in favor of overturning the ban on new physician-owned hospitals outlined broad cost savings if 2019's Medicare patients were treated at such facilities instead of a traditional hospital.

Hospitals 144
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Veterinarians and Pharmacists Discuss Challenges Around Pet Medications

Drug Topics

Veterinarians and veterinarian pharmacists weigh in on issues around working with pet medications.

551
551
article thumbnail

Merck’s Keytruda wins coveted FDA nod around surgery for early lung cancer—with a surprise

Fierce Pharma

Up until this point, immune checkpoint inhibitors have been allowed to treat early-stage non-small cell lung cancer (NSCLC) either before or after surgery. | Thanks to a new FDA approval for Merck's Keytruda, a continuous immunotherapy regimen around surgery is now available for patients with early-stage non-small cell lung cancer. The drug's label already includes an overall survival win from a key trial.

FDA 141
article thumbnail

‘We’re absolutely making it too hard’: The complexity of adult immunization delivery hinders vaccine uptake

STAT

Alison Buttenheim was floored by a sign she saw in her doctor’s office when she went to get the first jab of the two-dose shingles vaccine to protect her against painful flare-ups of varicella zoster. “Medicare patients cannot receive Tdap or zoster vaccines here. They need to obtain [them] at their pharmacy. If they receive it here, they need to pay out of pocket,” the notice read.

Vaccines 145
article thumbnail

Physical Health, Mental Health Associated With Insomnia in Veterans

Pharmacy Times

Study finds that probable insomnia disorder was associated with physical health problems and difficulty with anger in veterans.

158
158
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Has the science of anti-aging caught up with the dream of a longer life?

PharmaVoice

Billionaire investors and a new crop of longevity biotechs are betting big money on a lifespan-altering tipping point.

306
306
article thumbnail

Industry Voices—The beginning of the end for Alzheimer’s Dementia?

Fierce Healthcare

The approval of Leqembi by the Food and Drug Administration marks an exciting turning point for Alzheimer’s disease. | The approval of Leqembi by the FDA marks an exciting turning point for Alzheimer’s disease. There are big questions around costs, access, risk and efficacy in certain populations. The most urgent, overarching question is: How can we find patients who will benefit from the drug before their condition progresses outside of the treatment window?

FDA 142
article thumbnail

Vaccine Update: What Pharmacists Need to Know About ACIP’s New Guidelines

Drug Topics

Jean-Venable R. Goode, PharmD, director of the PGY1 Community Based Residency Program at Virginia Commonwealth University, discussed the new vaccine guidelines from ACIP.

Vaccines 551
article thumbnail

Gates Foundation spends $40M to boost mRNA vaccine production in Africa and beyond

Fierce Pharma

Following similar initiatives to bolster mRNA vaccine production and access in Africa, the Bill & Melinda Gates Foundation is providing new funding to a clutch of drugmakers. | Following similar initiatives to bolster mRNA vaccine production and access in Africa, the Bill & Melinda Gates Foundation is providing new funding to a clutch of drugmakers.

Vaccines 138
article thumbnail

AstraZeneca, maker of FluMist, seeks to allow at-home administration of vaccine

STAT

People eligible to use the only needle-free flu vaccine available in the United States may be able, next year, to give it to themselves or to eligible children at home. AstraZeneca, which makes the vaccine FluMist, announced Tuesday it has submitted to the Food and Drug Administration a supplemental biologics license application that would allow for self-administration of the vaccine by people ages 18 through 49, and would allow people 18 and older to give the vaccine to eligible children.

Vaccines 145
article thumbnail

Artificial Intelligence Helps Simplify Managed Care Pharmacy Workflow, Processes

Pharmacy Times

Artificial intelligence and machine learning can significantly benefit managed care pharmacy, specifically in contract reading and interpretation.

158
158
article thumbnail

The FDA might yank cold medicines from shelves — and that could be just the beginning

PharmaVoice

Phenylephrine’s future is up in the air with an FDA committee saying it’s not effective and a class action lawsuit alleging false advertising. What comes next could have big repercussions.

FDA 299
article thumbnail

HLTH23: Experts debate the flaws, future of Medicare Advantage

Fierce Healthcare

LAS VEGAS—Medicare Advantage (MA) has only grown over the last decade, and, in tandem, voices criticizing the program have gotten louder. | LAS VEGAS—Medicare Advantage has only grown over the last decade, and, in tandem, voices criticizing the program have gotten louder.

140
140
article thumbnail

The Role of Complementary and Alternative Medicine in Pharmacy

Drug Topics

It’s crucial to be openminded about these approaches, and to convey accurate information to patients in a nonjudgmental manner.

530
530
article thumbnail

Gut Health Has Impact on the Skin

Drug Topics

The gut-brain-skin axis is more important to overall health than previously understood, and prebiotics and probiotics play a large role in the benefits.

529
529
article thumbnail

Inside Insomnia: Pharmacist Management of Sleep Disorders

Drug Topics

Digging deeper into the cause of insomnia and counseling patients on lifestyle changes can help improve their sleep health.

524
524
article thumbnail

Diabetes Health Burden Negatively Impacts Quality of Life in Elderly Patients

Drug Topics

A study published in Primary Care Diabetes pinpoints those at most risk and recommends education to improve the quality of life in diagnosed elderly patients.

522
522
article thumbnail

Flip the Pharmacy Award Winners Recognized for Pharmacy Transformation Excellence

Drug Topics

The awards recognize the teams, coaches, and pharmacies that have demonstrated outstanding commitment to transforming community pharmacy practice.

article thumbnail

Reproducibility of Consecutive CGM Results in Cystic Fibrosis-Related Diabetes

Drug Topics

Researchers assessed the reproducibility of at-home CGM acquisitions with mixed meal tolerance tests among patients with CF-related diabetes who were not treated with insulin.

503
503
article thumbnail

HPV Vaccines Have Reshaped the Epidemiological Landscape

Drug Topics

Prophylactic HPV vaccines have demonstrated remarkable efficacy, exceeding 98%, and they are already proving to be effective in the prevention of anogenital warts, precancerous lesions, and cancer alike.

Vaccines 503